Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H29N7O6 |
Molecular Weight | 499.5197 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)N1CCC(CC#CC2=NC3=C(N=CN3[C@@H]4O[C@@H]([C@@H](O)[C@H]4O)C(=O)NC5CC5)C(N)=N2)CC1
InChI
InChIKey=SQJXTUJMBYVDBB-RQXXJAGISA-N
InChI=1S/C23H29N7O6/c1-35-23(34)29-9-7-12(8-10-29)3-2-4-14-27-19(24)15-20(28-14)30(11-25-15)22-17(32)16(31)18(36-22)21(33)26-13-5-6-13/h11-13,16-18,22,31-32H,3,5-10H2,1H3,(H,26,33)(H2,24,27,28)/t16-,17+,18-,22+/m0/s1
Molecular Formula | C23H29N7O6 |
Molecular Weight | 499.5197 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Evodenoson (ATL-313) is an agonist of adenosine A2A receptor. It exerts anti-inflammatory activity through activation of adenosine A2A receptors on CD4+ T cells and neutrophils. Evodenoson demonstrates efficacy in animal models of sepsis, myocardial infarction, allograft rejection and enteritis.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:38:00 GMT 2025
by
admin
on
Mon Mar 31 21:38:00 GMT 2025
|
Record UNII |
HZ03U10J2Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9675
Created by
admin on Mon Mar 31 21:38:00 GMT 2025 , Edited by admin on Mon Mar 31 21:38:00 GMT 2025
|
PRIMARY | |||
|
DTXSID40233476
Created by
admin on Mon Mar 31 21:38:00 GMT 2025 , Edited by admin on Mon Mar 31 21:38:00 GMT 2025
|
PRIMARY | |||
|
HZ03U10J2Z
Created by
admin on Mon Mar 31 21:38:00 GMT 2025 , Edited by admin on Mon Mar 31 21:38:00 GMT 2025
|
PRIMARY | |||
|
844873-47-8
Created by
admin on Mon Mar 31 21:38:00 GMT 2025 , Edited by admin on Mon Mar 31 21:38:00 GMT 2025
|
PRIMARY | |||
|
ZZ-41
Created by
admin on Mon Mar 31 21:38:00 GMT 2025 , Edited by admin on Mon Mar 31 21:38:00 GMT 2025
|
PRIMARY | |||
|
DB12295
Created by
admin on Mon Mar 31 21:38:00 GMT 2025 , Edited by admin on Mon Mar 31 21:38:00 GMT 2025
|
PRIMARY | |||
|
11627443
Created by
admin on Mon Mar 31 21:38:00 GMT 2025 , Edited by admin on Mon Mar 31 21:38:00 GMT 2025
|
PRIMARY | |||
|
C169974
Created by
admin on Mon Mar 31 21:38:00 GMT 2025 , Edited by admin on Mon Mar 31 21:38:00 GMT 2025
|
PRIMARY | |||
|
300000034187
Created by
admin on Mon Mar 31 21:38:00 GMT 2025 , Edited by admin on Mon Mar 31 21:38:00 GMT 2025
|
PRIMARY | |||
|
CHEMBL1950651
Created by
admin on Mon Mar 31 21:38:00 GMT 2025 , Edited by admin on Mon Mar 31 21:38:00 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|